Umibe5690 interesting points about DCVax-L blinded publication results for unmethylated MGMT. Why the larger market has not gotten wind of some of these amazing results is puzzling? All I know Linda Powers is accumulating shares. Hopefully all will work out for patients and longs someday.IMO
Umibe5690, thx for the points, not sure of the value of the 35 patient study, but, always good to understand all information in the literature. I was not sure that methylated tumors were highly mutated as mesenchymal tumors are. I understand methylated MOA as it relates to TMZ, an alkylating agent.